Procaps Group Net Borrowings Over Time
PROC Stock | USD 2.26 0.16 6.61% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Procaps Group Performance and Procaps Group Correlation. Procaps |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procaps Group. If investors know Procaps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procaps Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share 0.51 | Revenue Per Share 4.097 | Quarterly Revenue Growth 0.073 | Return On Assets 0.0628 |
The market value of Procaps Group SA is measured differently than its book value, which is the value of Procaps that is recorded on the company's balance sheet. Investors also form their own opinion of Procaps Group's value that differs from its market value or its book value, called intrinsic value, which is Procaps Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procaps Group's market value can be influenced by many factors that don't directly affect Procaps Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procaps Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procaps Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procaps Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Borrowings Analysis
Compare Procaps Group SA and related stocks such as Silver Spike Investment, Sihuan Pharmaceutical, and Phibro Animal Health Net Borrowings Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAHC | (80.1 M) | (80.1 M) | (80.1 M) | (80.1 M) | (1.1 M) | 62.1 M | (43.5 M) | (1.4 M) | 13.4 M | 60.4 M | 5.4 M | 50 M | 41.2 M | 47.4 M | 49.8 M |
COLL | 12 M | 12 M | 12 M | 12 M | 12 M | (1.3 M) | (2.7 M) | (2.7 M) | 10 M | 281.4 M | 281.4 M | (50 M) | (75 M) | (86.2 M) | (81.9 M) |
ANIP | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | 138.2 M | 75 M | (294 K) | 72.3 M | (28.9 M) | (121.5 M) | (534 K) | 99 M | (3 M) | (2.7 M) | (2.6 M) |
PBH | 599.8 M | 599.8 M | (158.1 M) | (48 M) | 640 M | 350 M | 1.4 B | (209.5 M) | (200 M) | (74.6 M) | (267.7 M) | (9.1 M) | (135 M) | (121.5 M) | (115.4 M) |
RGC | 481 K | 481 K | 481 K | 481 K | 481 K | 481 K | 481 K | 481 K | 481 K | 988.1 K | 612.1 K | (432 K) | (432 K) | (388.8 K) | (369.3 K) |
Procaps Group SA and related stocks such as Silver Spike Investment, Sihuan Pharmaceutical, and Phibro Animal Health Net Borrowings description
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.My Equities
My Current Equities and Potential Positions
Procaps Group SA | PROC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Luxembourg |
Exchange | NASDAQ Exchange |
USD 2.26
Check out Procaps Group Performance and Procaps Group Correlation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Procaps Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.